2026 · 2nd Quarter (Apr 1 - June 30)
Filed by BLUEBIRD STRATEGIES.
Open official filingSource-reported fields
Literal source text
Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.
Literal federal measure citations: H.R. 9061
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
